Christopher D. Maggiore - 02 Jun 2021 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Christopher D. Maggiore
Issuer symbol
ZIVO
Transactions as of
02 Jun 2021
Net transactions value
+$500,000
Form type
4
Filing time
04 Jun 2021, 15:44:25 UTC
Next filing
15 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIVO Common Stock Purchase $499,000 +100,000 +17% $4.99 704,211 02 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Common Stock Purchase Warrant Purchase $1,000 +100,000 $0.0100* 100,000 02 Jun 2021 Common Stock 100,000 $5.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The share amount has been adjusted to reflect the reverse stock split effective on May 28, 2021 whereby each eighty shares of common stock issued and outstanding prior to the split were combined and converted into one share of common stock.